Inventor · disambiguated record
Juergen Roemisch
Also filed as: ROEMISCH JUERGEN · ROEMISCH JUERGEN ROLAND
14 granted patents·17 pending applications·165 citations·filing 2000–2025
91Inventor score
Top patents by PatentIndex Score
31 records- 0193US6737405B2Stabilized protein preparation and process for its preparationAVENTIS BEHRING GMBH·Filed 2001·Granted May 18, 2004·55 cites·11 claims
- 0289US8518452B2Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acidBJORNSTRUP KIM·Filed 2008·Granted Aug 27, 2013·55 cites·15 claims
- 0385US6677440B1Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatographyAVENTIS BEHRING GMBH·Filed 2000·Granted Jan 13, 2004·22 cites·17 claims
- 0483US6831167B2Mutants of the factor VII-activating protease and detection methods using specific antibodiesAVENTIS BEHRING GMBH·Filed 2001·Granted Dec 14, 2004·9 cites·6 claims
- 0579US7153679B2Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosisAVENTIS BEHRING GMBH·Filed 2003·Granted Dec 26, 2006·9 cites·20 claims
- 0679US6670455B1Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatographyAVENTIS BEHRING GMBH·Filed 2000·Granted Dec 30, 2003·12 cites·13 claims
- 0769US7892842B2Procedure for the determination of the activity of the protease which activates factor VII from protein solutionsCSL BEHRING GMBH·Filed 2008·Granted Feb 22, 2011·0 cites·19 claims
- 0865US7863009B2Mutants of the factor VII-activating protease and detection methods using specific antibodiesCSL BEHRING GMBH·Filed 2008·Granted Jan 4, 2011·0 cites·8 claims
- 0963US7442514B2Mutants of the factor VII-activating protease and detection methods using specific antibodiesCSL BEHRING GMBH·Filed 2004·Granted Oct 28, 2008·0 cites·19 claims
- 1060US2008317735A1Pharmaceutical preparation with RNA as hemostasis cofactorZLB BEHRING GMBH·Filed 2008·Application pending·0 cites
- 1159US2004162412A1Stabilized protein preparation and process for its preparationAVENTIS BEHRING GMBH·Filed 2004·Application pending·0 cites
- 1257US6395881B1Separation of antithrombin III α and β variants by cyclodextrin-modified micellar electrokinetic chromatographyAVENTIS BEHRING GMBH·Filed 2001·Granted May 28, 2002·3 cites·34 claims
- 1356US12274738B2FX activation process and its use in the preparation of a FXa compositionOCTAPHARMA AG·Filed 2019·Granted Apr 15, 2025·0 cites·20 claims
- 1456US7803569B2Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutationsCSL BEHRING GMBH·Filed 2006·Granted Sep 28, 2010·0 cites·20 claims
- 1553US2025222079A1Fx activation process and its use in the preparation of a fxa compositionOCTAPHARMA AG·Filed 2025·Application pending·0 cites
- 1651US2005075301A1Pharmaceutical preparation with RNA as hemostasis cofactorFiled 2003·Application pending·0 cites
- 1750US2004186277A1Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatographyAVENTIS BEHRING GMBH·Filed 2003·Application pending·0 cites
- 1850US2004063187A1Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of chromatographyAVENTIS BEHRING GMBH·Filed 2003·Application pending·0 cites
- 1949US2007212344A1Pharmaceutical preparation with RNA as hemostasis cofactorAVENTIS BEHRING GMBH·Filed 2007·Application pending·0 cites
- 2049US2015031621A1Method for purification of complement factor hOCTAPHARMA AG·Filed 2014·Application pending·0 cites
- 2147US2003124622A1Procedure for the determination of the activity of the protease which activates factor VII from protein solutionsFiled 2002·Application pending·0 cites
- 2246US8809510B2Method for purification of complement factor HBRANDSTAETTER HUBERT·Filed 2011·Granted Aug 19, 2014·0 cites·5 claims
- 2344US2015250879A1Test for hemolytic potential of pharmaceutical products and formulations for risk minimizationOCTAPHARMA AG·Filed 2013·Application pending·0 cites
- 2443US7829095B2Inhibitory monoclonal antibody against blood clotting factor VII-activating proteaseCSL BEHRING GMBH·Filed 2003·Granted Nov 9, 2010·0 cites·2 claims
- 2543US2015211064A1Assay and method for the identification of individual responsiveness to immunoglobulin therapyMEUER STEFAN·Filed 2012·Application pending·0 cites
- 2642US2004229795A1Use of antithrombin III for the prophylaxis and therapy of diseasesAVENTIS BEHRING GMBH·Filed 2004·Application pending·0 cites
- 2742US2004161810A1Monoclonal antibodies specific for latent antithrombin III and the use thereofFiled 2003·Application pending·0 cites
- 2841US2003134796A1Antithrombin for the prevention and therapy of vasculoproliferative disordersFiled 2002·Application pending·0 cites
- 2934US2003077271A1Use of coagulation factor VII-activating protease for the prophylaxis and therapy of vasoproliferative disordersFiled 2002·Application pending·0 cites
- 3032US2003007966A1Pharmaceutical preparation for the inhalation of antithrombin in inflammatory lung diseases and ARDSFiled 2002·Application pending·0 cites
- 3131US2002119143A1Antithrombin III for disorders caused by angiogenesisFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Juergen Roemisch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →